Page 16 - Benjamin Pinsky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Study reveals COVID-19 severity is affected by proportion of antibodies targeting crucial viral protein ANI | Updated: Dec 25, 2020 09:48 IST Washington [US], December 25 (ANI): A recent study has revealed that COVID-19 antibodies wane significantly within several months of infection and preferentially target a different part of the virus in mild cases of COVID-19 than in comparison to severe ones. The findings which were published in Science Immunology identifies new links between the course of the disease and a patient's immune response to it. They also...

COVID-19 antibodies preferentially target a different part of the virus in mild cases of COVID-19 than they do in severe cases, and wane significantly within several months of infection, according to a new study by researchers at Stanford Medicine.

 E-Mail COVID-19 antibodies preferentially target a different part of the virus in mild cases of COVID-19 than they do in severe cases, and wane significantly within several months of infection, according to a new study by researchers at Stanford Medicine. The findings identify new links between the course of the disease and a patient's immune response. They also raise concerns about whether people can be re-infected, whether antibody tests to detect prior infection may underestimate the breadth of the pandemic and whether vaccinations may need to be repeated at regular intervals to maintai...

$3.7 million NIH grant supports development of biosensor technology for diagnosing viral diseases For over ten years, Ali Yanik has been working to develop novel biosensor technology to provide rapid, low-cost testing for disease diagnostics and precision medicine. Now, with a five-year, $3.7 million grant from the National Institutes of Health, he and his collaborators are poised to complete the development and validation of a prototype and begin testing it in the field for detection of dengue fever, yellow fever, and Zika virus infections. "We're confident in being able to do this and get i...

 E-Mail For over ten years, Ali Yanik has been working to develop novel biosensor technology to provide rapid, low-cost testing for disease diagnostics and precision medicine. Now, with a five-year, $3.7 million grant from the National Institutes of Health, he and his collaborators are poised to complete the development and validation of a prototype and begin testing it in the field for detection of dengue fever, yellow fever, and Zika virus infections. "We're confident in being able to do this and get it into the field for testing," said Yanik, an assistant professor of electrical and comp...